ESENTRA 120
Brand Name: ESENTRA 120
Composition (Active Ingredient): Denosumab Solution for Injection (120 mg/1.7 mL, which equals 70 mg/mL)
Marketed/Manufactured By: INTAS (Intas Pharmaceuticals Ltd.)
Product Description
Medical Info
ESENTRA 120 is a prescription-strength Denosumab solution for injection, meticulously developed by INTAS Pharmaceuticals. Formulated at a concentration of 70 mg/mL, each single-use vial delivers a high-potency 120 mg dose within 1.7 mL of solution. This sterile medication is engineered strictly for subcutaneous use only, playing a critical role in specialized bone-targeted medical therapies. It must be administered under proper clinical supervision, and patients should strictly follow the storage guidelines on the packaging. For full administration protocols, precise dosage schedules, and vital safety precautions, healthcare providers and patients must refer to the comprehensive prescribing details found in the enclosed package insert.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
